![]() |
市場調查報告書
商品編碼
2046034
一次性安全採血針市場 - 全球產業規模、佔有率、趨勢、機會、預測:按產品類型、規格、應用、最終用戶、地區和競爭格局分類,2021-2031年Disposable Safety Lancets Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Gauge Size, By Application, By End User, By Region & Competition, 2021-2031F |
||||||
全球一次性安全採血針市場預計將從 2025 年的 6.5271 億美元成長到 2031 年的 9.0821 億美元,複合年成長率為 5.66%。
這些無菌一次性裝置專為毛細血管採血而設計,其內部回縮機制可有效防止針刺傷和交叉感染。市場成長的主要驅動力是嚴格的醫療法規,這些法規要求使用安全設計的裝置,以保護醫護人員和患者免受血液傳播病原體的侵害。此外,臨床環境中對感染控制的日益重視,以及老年人口的成長,不斷推高了對這些關鍵診斷裝置的需求,為持續擴張奠定了堅實的基礎,使其不易受行業短期波動的影響。需要定期監測血糖值的慢性疾病在全球範圍內的日益普遍,是推動市場規模成長的根本原因。根據國際糖尿病聯盟 (IDF) 預測,到 2024 年,全球約有 5.89 億成年人患有糖尿病,這極大地促進了市場需求。然而,這種強勁的需求在一定程度上受到一個顯著挑戰的限制:持續血糖監測 (CGM) 系統的日益普及。 CGM 技術將減少指尖穿刺的頻率,從而限制傳統採血針的使用範圍。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 6.5271億美元 |
| 市場規模:2031年 | 9.0821億美元 |
| 複合年成長率:2026-2031年 | 5.66% |
| 成長最快的細分市場 | 壓力激活式安全採血針 |
| 最大的市場 | 北美洲 |
全球糖尿病和其他慢性疾病盛行率的激增是推動市場擴張的主要動力,也因此對持續血糖值監測和診斷篩檢的需求變得特別迫切。慢性疾病的激增迫使醫療系統儲備充足的毛細血管採血設備,以有效管理患者的檢測流程。隨著檢測量的增加,大量未確診患者湧入醫療系統,進一步加速了這些無菌設備的消耗。國家健康數據凸顯了這種診斷需求的普遍性。根據美國疾病管制與預防中心 (CDC) 2024 年 5 月發布的《國家糖尿病統計報告》,9,760 萬 18 歲及以上的美國人處於糖尿病前期,如此大規模的人群推動了篩檢頻率的提高,進而帶動了一次性採血採血針銷量的成長。為防止針刺傷而訂定的嚴格法規,強制要求從標準針頭轉向安全設計的採血針,從根本上改變了產品的使用方式。 Regulators are proactively implementing protocols to mitigate the transmission of bloodborne pathogens among healthcare workers, prioritizing devices with automated storage capabilities despite potentially higher costs. This burulatory capabilities despite potentially higher costs。 by the 感染疾病 that safety devices aim to alleviate. The World Health Organization's (WHO) April 2024 Global Hepatitis Report noted that 1.3 million people died from viral hepatitis in 2022, hight ious urables sooly slekk sabled採血針很多詞. Furthermore, increased financial investment in healthcare infrastructure is also driving the transition to these high-quality safety devices. According to projections in the Centre for Medicare & Medicaid Services (CMS) June 2024 National 醫療費用支出 2032030 2002099 increase at an annual rate of 5.6%, which will ensure that healthcare facilities have the necessary financial resources to procure these essential safety devices.
全球一次性安全採血針市場成長的主要障礙是持續血糖監測(CGM)系統的快速普及。這些基於感測器的設備使患者能夠即時監測血糖值,無需反覆指尖採血,而這正是安全採血針的唯一功能。隨著醫療標準越來越重視CGM感測器提供的更優血糖控制,採血針的常規需求正在下降,其使用範圍逐漸局限於偶爾的校準和備用情況。這種轉變從根本上降低了常規糖尿病管理的採血針消耗量。在醫療資源豐富的市場,感測器技術的報銷機製完善,這種技術替代尤為顯著。例如,英國糖尿病協會發布的「2024年全國糖尿病妊娠審計」數據顯示,97.5%的第一型糖尿病孕婦正在使用持續血糖監測系統。在特定患者群體中近乎完全的市場滲透清楚地表明,感測器正在有效地取代傳統的血液採樣方法,因此,一次性安全採血針在慢性病護理領域的銷售成長潛力受到了顯著限制。
One of the key trends transforming the manufacturing landscape is the shift towards biodegradable and environmentally friendly materials as industry 領導企業 decarbonize their supply chains and strive to comply with evolations enableity 醫療設備 suppronmental. capillary blood collection tools to reduce plastic 廢棄物. By incorporating recycled polymers and bio-based resins, they are minimizing their environmental impact while maintaining stringent sterility candar their environmental impact while maintaining stringent sterility dar darstopleh. prioritizing environmentally conscious suppliers, forcing manufacturers to fundamentally rethink their production lifecycles. For example, Becton Dickinson & Company's FY2024 Corporate Sustainability Report, published in July 2025, highlights a 20% reduction in Scope 1 and 2 greenhouse gas 排放 in FY2024 compared to 2019 基準值, underscoring the industry-wide effort to reduce the carbon footprint of disposable diagnostic consumables.與此同時,在遠端患者監護和分散式醫療模式持續擴展的市場上,D2C(直接從市場上的商業結構流通結構正在推動隨著越來越多的慢性病患者在家中管理自身健康,對傳統以醫院為中心的供應鏈的依賴正逐漸轉向以訂閱方式提供糖尿病必需品的電商平台。這種數位化獲取途徑使得接受線上諮詢的患者更容易獲得診斷工具,有效規避了實體藥局的限制。根據美國醫學會(AMA)2025年12月發布的《政策研究展望》報告,到2024年,71.4%的醫生將使用遠端醫療服務,這表明遠距醫療服務的結構性擴張直接支持了消費者對安全採血針等醫療必需品宅配日益成長的需求。
The Global Disposable Safety Lancets Market is projected to expand from USD 652.71 Million in 2025 to USD 908.21 Million by 2031, exhibiting a Compound Annual Growth Rate (CAGR) of 5.66%. These sterile, single-use devices are designed for capillary blood sampling, featuring internal retraction mechanisms that effectively prevent needle-stick injuries and cross-contamination. Market growth is predominantly fueled by stringent healthcare regulations that mandate the use of safety-engineered devices to safeguard both healthcare professionals and patients from bloodborne pathogens. Furthermore, a heightened emphasis on infection control within clinical environments, coupled with a growing geriatric population, consistently drives demand for these crucial diagnostic instruments, establishing a firm base for sustained expansion independent of transient industry shifts. The increasing global prevalence of chronic conditions necessitating regular blood glucose monitoring acts as a fundamental driver for market volume. In 2024, approximately 589 million adults worldwide were living with diabetes, as reported by the International Diabetes Federation, contributing significantly to this demand. However, this robust demand is somewhat tempered by a notable challenge: the rising adoption of continuous glucose monitoring (CGM) systems. CGM technology reduces the frequency of required finger-stick testing, thereby limiting the overall expansion of traditional lancet usage.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 652.71 MIllion |
| Market Size 2031 | USD 908.21 MIllion |
| CAGR 2026-2031 | 5.66% |
| Fastest Growing Segment | Pressure Activated Safety Lancets |
| Largest Market | North America |
Market Driver
The escalating global prevalence of diabetes and other chronic diseases serves as a primary catalyst for the market's expansion, creating a critical need for consistent blood glucose monitoring and diagnostic screenings. This surge in chronic conditions compels healthcare systems to maintain substantial inventories of capillary sampling devices to effectively manage patient testing protocols. As the volume of required tests grows, the influx of undiagnosed populations into the healthcare system further amplifies the consumption rate of these sterile devices. The profound scope of this diagnostic imperative is highlighted by national health data; the Centers for Disease Control and Prevention's May 2024 'National Diabetes Statistics Report' indicated that 97.6 million Americans aged 18 or older have prediabetes, a significant demographic that drives increased screening frequency and, consequently, higher unit sales for disposable lancets. The implementation of rigorous regulations aimed at preventing needlestick injuries fundamentally transforms product adoption by enforcing a shift from standard needles to safety-engineered mechanisms. Regulatory bodies are actively implementing protocols to mitigate the transmission of bloodborne pathogens among healthcare workers, prioritizing devices with automatic retraction features despite their potentially higher cost. This regulatory impetus is underscored by the severe public health burden of infectious diseases that safety devices aim to reduce; the World Health Organization's April 2024 'Global Hepatitis Report 2024' noted that viral hepatitis caused 1.3 million deaths in 2022, emphasizing the urgent need for infection control measures like single-use safety lancets. Moreover, increasing financial investments in medical infrastructure support this transition towards premium safety devices. Projections from the Centers for Medicare & Medicaid Services' June 2024 'National Health Expenditure 2023-2032' report indicate health spending will grow by 5.6% annually, providing the necessary fiscal capacity for healthcare facilities to procure these essential safety tools.
Market Challenge
The principal obstacle to the growth of the Global Disposable Safety Lancets Market is the rapid and widespread adoption of continuous glucose monitoring (CGM) systems. These sensor-based devices empower patients to monitor glucose levels in real-time, eliminating the need for the repetitive finger-stick testing that constitutes the sole function of safety lancets. As healthcare standards increasingly favor the superior glycemic control offered by CGM sensors, the daily necessity for lancets is diminishing, relegating their use to occasional calibration or backup scenarios. This shift leads to a structural decline in the consumption volume for routine diabetes management. This technological displacement is particularly pronounced in advanced healthcare markets where reimbursement for sensor technology is robust. For instance, data from the Diabetes UK 2024 National Pregnancy in Diabetes Audit revealed that 97.5% of pregnant women with Type 1 diabetes were utilizing continuous glucose monitoring systems. This nearly complete market penetration within specific patient demographics clearly illustrates how effectively sensor adoption is replacing traditional blood sampling methods, thereby significantly limiting the potential for volume growth of disposable safety lancets in the chronic care sector.
Market Trends
A significant trend reshaping the manufacturing landscape is the transition toward biodegradable and eco-friendly materials, as industry leaders strive to decarbonize their supply chains and comply with evolving environmental mandates. Medical device companies are increasingly redesigning single-use capillary sampling tools to reduce plastic waste, integrating recycled polymers and bio-based resins that maintain stringent sterility standards while simultaneously minimizing ecological impact. This strategic shift is largely a direct response to institutional procurement policies that prioritize environmentally responsible suppliers, compelling manufacturers to fundamentally revise their production lifecycles. Becton, Dickinson and Company's July 2025 'FY 2024 Corporate Sustainability Report', for example, highlighted a 20% decrease in Scope 1 and 2 greenhouse gas emissions in fiscal year 2024 compared to its 2019 baseline, underscoring the sector-wide dedication to reducing the carbon footprint of disposable diagnostic consumables. Concurrently, the proliferation of direct-to-consumer and online retail channels is fundamentally altering product distribution, driven by the sustained expansion of remote patient monitoring and decentralized care models. As patients increasingly manage chronic conditions from their homes, the reliance on conventional hospital-based supply chains is shifting towards e-commerce platforms that facilitate subscription-based delivery for essential diabetes supplies. This digitalization of access ensures that diagnostic tools remain readily available to patients engaging in virtual consultations, effectively bypassing the limitations of physical pharmacies. According to the American Medical Association's December 2025 'Policy Research Perspectives' report, 71.4% of physicians utilized telehealth services in 2024, indicating a structural adoption that directly supports the growing consumer demand for home-delivered medical necessities such as safety lancets.
Report Scope
In this report, the Global Disposable Safety Lancets Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Disposable Safety Lancets Market.
Global Disposable Safety Lancets Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: